68 related articles for article (PubMed ID: 15364127)
1. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
Hu Z; Wei Q; Wang X; Shen H
Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
[TBL] [Abstract][Full Text] [Related]
2. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis.
Feng Z; Ni Y; Dong W; Shen H; Du J
Mol Biol Rep; 2012 Jan; 39(1):57-69. PubMed ID: 21614524
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans.
Chang JS; Wrensch MR; Hansen HM; Sison JD; Aldrich MC; Quesenberry CP; Seldin MF; Kelsey KT; Kittles RA; Silva G; Wiencke JK
Int J Cancer; 2008 Nov; 123(9):2095-104. PubMed ID: 18709642
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in
Chen YP; Liao Y; Yuan L; Huang XK; Ruan JC; Lin HR; Miao L; Zhuo ZJ
Cancer Innov; 2022 Jun; 1(1):70-79. PubMed ID: 38089451
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of XPD and XPG gene polymorphism in oral squamous cell carcinoma and tobacco chewers: An observational study.
Shrivastava P; Gosavi S; Ghatge D; Naik A; Marlapalle A; Krishna A
J Oral Maxillofac Pathol; 2022; 26(4):518-523. PubMed ID: 37082048
[TBL] [Abstract][Full Text] [Related]
6. Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium.
Wang M; Liu H; Liu Z; Yi X; Bickeboller H; Hung RJ; Brennan P; Landi MT; Caporaso N; Christiani DC; Doherty JA; ; Amos CI; Wei Q
Carcinogenesis; 2016 Sep; 37(9):888-896. PubMed ID: 27288692
[TBL] [Abstract][Full Text] [Related]
7. DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.
Doherty JA; Sakoda LC; Loomis MM; Barnett MJ; Julianto L; Thornquist MD; Neuhouser ML; Weiss NS; Goodman GE; Chen C
Int J Mol Epidemiol Genet; 2013; 4(1):11-34. PubMed ID: 23565320
[TBL] [Abstract][Full Text] [Related]
8. Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso.
Adico MDW; Zouré AA; Sombié HK; Kiendrebeogo TI; Dabré S; Amegnona LJ; Bakyono BS; Traoré L; Ouedraogo TC; Ouedraogo RA; Zohoncon TM; Yonli AT; Bayala B; Bambara HA; Djigma FW; Simpore J
Mol Genet Genomic Med; 2023 Apr; 11(4):e2134. PubMed ID: 36594475
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung.
Lee MS; Liu CY; Su L; Christiani DC
Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of the association between XPD rs13181 polymorphism and lung cancer risk.
Wu HY; Ding LY
Tumour Biol; 2014 Aug; 35(8):8125-32. PubMed ID: 24845027
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in multiple biologic pathways, flavonoid intake, and breast cancer.
Khankari NK; Bradshaw PT; McCullough LE; Teitelbaum SL; Steck SE; Fink BN; Xu X; Ahn J; Ambrosone CB; Crew KD; Terry MB; Neugut AI; Chen J; Santella RM; Gammon MD
Cancer Causes Control; 2014 Feb; 25(2):215-26. PubMed ID: 24281852
[TBL] [Abstract][Full Text] [Related]
12. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.
Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T
PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population.
Yuan H; Li H; Ma H; Niu Y; Wu Y; Zhang S; Hu Z; Shen H; Chen N
Exp Ther Med; 2012 Apr; 3(4):719-724. PubMed ID: 22969958
[TBL] [Abstract][Full Text] [Related]
14. Assessment of DNA damage and repair in adults consuming allyl isothiocyanate or Brassica vegetables.
Charron CS; Clevidence BA; Albaugh GA; Kramer MH; Vinyard BT; Milner JA; Novotny JA
J Nutr Biochem; 2013 May; 24(5):894-902. PubMed ID: 22902324
[TBL] [Abstract][Full Text] [Related]
15. Common polymorphisms in CYP1A1, GSTM1, GSTT1, GSTP1 and XPD genes and endogenous DNA damage.
Wlodarczyk M; Nowicka G
Mol Biol Rep; 2012 May; 39(5):5699-704. PubMed ID: 22183307
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.
Kiyohara C; Takayama K; Nakanishi Y
J Nucleic Acids; 2010 Oct; 2010():701760. PubMed ID: 20981350
[TBL] [Abstract][Full Text] [Related]
17. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
[TBL] [Abstract][Full Text] [Related]
18. Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.
Gandara DR; Kawaguchi T; Crowley J; Moon J; Furuse K; Kawahara M; Teramukai S; Ohe Y; Kubota K; Williamson SK; Gautschi O; Lenz HJ; McLeod HL; Lara PN; Coltman CA; Fukuoka M; Saijo N; Fukushima M; Mack PC
J Clin Oncol; 2009 Jul; 27(21):3540-6. PubMed ID: 19470925
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer susceptibility model based on age, family history and genetic variants.
Young RP; Hopkins RJ; Hay BA; Epton MJ; Mills GD; Black PN; Gardner HD; Sullivan R; Gamble GD
PLoS One; 2009; 4(4):e5302. PubMed ID: 19390575
[TBL] [Abstract][Full Text] [Related]
20. Low-dose-radiation stimulated natural chemical and biological protection against lung cancer.
Scott BR
Dose Response; 2008; 6(3):299-318. PubMed ID: 18846259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
